Latest Biotech News

Cutting-edge studies illuminate new frontiers in oncology. Glycan-dependent T cell recruiting (GlyTR) compounds designed at UC Irvine demonstrate pan-cancer immunotherapy efficacy by selectively...

Recent regulatory advancements fuel treatment options in oncology and rare diseases. Eli Lilly’s oral selective estrogen receptor degrader imlunestrant received FDA approval for late-stage,...

Recent research is unlocking complex genomic and molecular landscapes across diseases. New chromosome-level genome assemblies of vulnerable species like the Sichuan taimen provide key conservation...

Technological integration in healthcare accelerates innovation. Ultromics’ Echogo AI system advances cardiac amyloidosis diagnosis by improving early detection and reducing false positives. InfEHR...

The NIH launched a $87 million Standardized Organoid Modeling Center to accelerate organoid research reproducibility, aiming to reduce reliance on animal testing. In parallel, artificial tissue...

Concept Life Sciences expanded its integrated drug discovery facilities in the U.K., consolidating chemistry, ADMET, and screening biology capabilities to streamline early-stage innovation....

Innovations offering sustainable agricultural and environmental impact solutions emerge prominently. Fully biodegradable hydrogels developed collaboratively by the Free University of Bozen-Bolzano...

Crinetics Pharmaceuticals has secured FDA approval for Palsonify (paltusotine), the first once-daily oral therapy for acromegaly patients who are either ineligible for surgery or have inadequately...

President Donald Trump announced a 100% tariff on branded pharmaceutical imports effective October 1, sparking widespread concern across the biotech industry. The administration indicated...

Recent breakthroughs harness artificial intelligence to improve diagnostic accuracy in cancer and cardiovascular diseases. Researchers developed a deep learning model that enhances the...

Concept Life Sciences expanded its integrated drug discovery facilities in the UK, consolidating chemistry, ADMET, and biology to accelerate early-stage research. This enhancement supports...

Leading cancer centers presented breakthroughs in radiation oncology at the 2025 ASTRO meeting. UCLA and University of Cincinnati researchers unveiled advancements including targeted radioactive...

Recent research sheds light on molecular targets and novel treatments across oncology and rare diseases. UCLA scientists identified a protein IGF2BP3 that rewires leukemia metabolism and RNA...

Emerging cell and gene therapy innovations signal progress in treating diverse diseases. CRISPR-edited 'hypoimmune' pancreatic islet cells can now be transplanted without immunosuppression for...

Policy and market dynamics are rapidly evolving in biotech. The U.S. Department of Health and Human Services submitted a proposed rule to introduce a Most-Favored-Nation (MFN) prescription drug...

Eli Lilly has launched a new biotech incubator in San Diego, Gateway Labs, offering collaborative lab and office spaces with access to expertise aiming to foster innovation. The location spans...

Diverse biomedical breakthroughs emerged across infectious disease, developmental biology, and neurodegenerative conditions. The University of the Sunshine Coast secured approval for the world’s...

Crinetics Pharmaceuticals secured FDA approval for Palsonify (paltusotine), marking its first authorized treatment targeting acromegaly, a rare endocrine disorder caused by excessive growth...

The FDA authorized Eli Lilly's imlunestrant (Inluriyo), an oral selective estrogen receptor degrader, for treatment of adults with estrogen receptor-positive, HER2-negative advanced or metastatic...

President Donald Trump announced a 100% tariff on branded pharmaceutical imports effective October 1, with exemptions for companies building manufacturing plants in the U.S. This move aims to...